Researchers developed a small molecule drug showing potential as a new treatment for multiple sclerosis (MS). This research focuses on targeting the glutamate system rather than the immune system, differing from existing MS therapies.
Researchers developed a small molecule drug showing potential as a new treatment for multiple sclerosis (MS). This research focuses on targeting the glutamate system rather than the immune system, differing from existing MS therapies.
Share this Article
Recommended